Charles Schwab Investment Management Inc Care Dx, Inc. Transaction History
Charles Schwab Investment Management Inc
- $515 Billion
- Q3 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Care Dx, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 499,480 shares of CDNA stock, worth $10.3 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
499,480
Previous 485,933
2.79%
Holding current value
$10.3 Million
Previous $7.55 Million
106.64%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding CDNA
# of Institutions
218Shares Held
51.1MCall Options Held
97.3KPut Options Held
43.3K-
Black Rock Inc. New York, NY5.29MShares$109 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.54MShares$93.5 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.15MShares$64.8 Million1.65% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.99MShares$61.6 Million0.89% of portfolio
-
State Street Corp Boston, MA2.04MShares$42 Million0.0% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $1.1B
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...